John Paulson's ITCI Position Overview
John Paulson (via Paulson & Co. Inc.) currently holds 21,500 shares of Intra-Cellular Therapies Inc (ITCI) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, John Paulson has initiated a new position in ITCI, representing a fresh investment thesis on this company.
Analysis based on 13F filings available since 2013 Q2
John Paulson's Intra-Cellular Therapies (ITCI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Intra-Cellular Therapies (ITCI) Trades by John Paulson
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2025 | +21,500 | New Buy | 21,500 | $131.92 |
| Q2 2025 | -21,500 | Sold Out | 21,500 | $0.00 |
John Paulson's Intra-Cellular Therapies Investment FAQs
John Paulson first purchased Intra-Cellular Therapies Inc (ITCI) in Q1 2025, acquiring 21,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson has held Intra-Cellular Therapies Inc (ITCI) for 2 quarters since Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson's largest addition to Intra-Cellular Therapies Inc (ITCI) was in Q1 2025, adding 21,500 shares worth $2.84 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q2 2025, John Paulson's firm, Paulson & Co. Inc., owns 21,500 shares of Intra-Cellular Therapies Inc (ITCI), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q2 2025 filing, Intra-Cellular Therapies Inc (ITCI) represents approximately 0.00% of John Paulson's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson's peak holding in Intra-Cellular Therapies Inc (ITCI) was 21,500 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.